TNSN05325A1 - N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO - Google Patents
N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETOInfo
- Publication number
- TNSN05325A1 TNSN05325A1 TNP2005000325A TNSN05325A TNSN05325A1 TN SN05325 A1 TNSN05325 A1 TN SN05325A1 TN P2005000325 A TNP2005000325 A TN P2005000325A TN SN05325 A TNSN05325 A TN SN05325A TN SN05325 A1 TNSN05325 A1 TN SN05325A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pyrazolo
- sulfonamides
- pyrimidin
- phenyl
- substituted
- Prior art date
Links
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 102000027484 GABAA receptors Human genes 0.000 abstract 2
- 108091008681 GABAA receptors Proteins 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000006806 disease prevention Effects 0.000 abstract 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to compounds of Formula (I): wherein R1, R2 and R3 are as defined in the claims. The compounds have specific affinity for the GABAA receptor and are therefore useful in the treatment and prevention of diseases modulated by the alpha1- and alpha 2- GABAA receptors.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301746A ES2222813B1 (en) | 2003-07-24 | 2003-07-24 | N- (3- (3-SUBSTITUTES-PIRAZOLO (1,5-A) PIRIMIDIN-7-IL) -PENYL) -SULPHONAMIDS AND RELATED COMPOSITIONS AND METHODS |
| PCT/EP2004/008208 WO2005014597A1 (en) | 2003-07-24 | 2004-07-22 | N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TNSN05325A1 true TNSN05325A1 (en) | 2007-07-10 |
Family
ID=40565145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2005000325A TNSN05325A1 (en) | 2003-07-24 | 2005-12-22 | N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO |
Country Status (2)
| Country | Link |
|---|---|
| TN (1) | TNSN05325A1 (en) |
| ZA (1) | ZA200601170B (en) |
-
2004
- 2004-07-22 ZA ZA200601170A patent/ZA200601170B/en unknown
-
2005
- 2005-12-22 TN TNP2005000325A patent/TNSN05325A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200601170B (en) | 2007-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
| ATE384061T1 (en) | IMIDAZO AND THIAZOLOPYRIDINES AS JAK3 KINASE INHIBITORS | |
| CY1109906T1 (en) | COPPER C3-KYANO PRODUCER | |
| UA83311C2 (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
| TW200745121A (en) | Chemical compound | |
| MXPA05007115A (en) | Novel cb 1 receptor inverse agonists. | |
| TW200608966A (en) | 3-aminocyclopentanecarboxamides as modulators of chemokine receptors | |
| UA83917C2 (en) | 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors | |
| TW200510422A (en) | N-[3-(3-substituted-pyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-sulfonamides and compositions and methods related thereto | |
| TW200716134A (en) | Tricyclic opioid modulators | |
| BR0318521A (en) | arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods | |
| WO2006055434A3 (en) | Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease | |
| TW200626600A (en) | Octahydropyrrolo[3, 4-c]pyrrole derivatives | |
| MY139290A (en) | Substituted pyrrolidine and related compounds | |
| TNSN05325A1 (en) | N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO | |
| TW200504074A (en) | 7-substituted 3-nitro-pyrazolo[1,5-a]pyrimidines and compositions and methods related thereto | |
| TW200621223A (en) | Acyclic 1,3-diamines and uses therefor | |
| UA81464C2 (en) | NOVEL AMINOPYRIDINE DERIVATIVES AS mGIuR5 ANTAGONISTS | |
| GB2425309A (en) | C2-fluoro pyrrolo[2,1-c][1,4]benzodiazepine dimers | |
| TW200640929A (en) | N-[3-(8-substituted-imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-sulfonamides, n-[3-(8-substituted-imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides, compositions, and methods related thereto | |
| TNSN05324A1 (en) | 7-substituted 3-nitro-pyrazolo `1,5-a! pyrimidines | |
| UA83142C2 (en) | 3-aminocyclopentane carboxyamidine as modulators of chemokine receptors | |
| UA89046C2 (en) | Benzohydroazepine derivatives, phrmaceutical composition and methods for treating cardiovascular diseases |